<?xml version="1.0" encoding="UTF-8"?>
<document id="28776573">
	<sentence id="s1" text="The more common member of this family, intraductal papillary mucinous neoplasm, often carries genetic alterations typical of pancreatic infiltrating ductal adenocarcinoma (KRAS, TP53, and CDKN2A) but additionally has mutations in GNAS and RNF43 genes.">
		<entity id="s1.e1" charOffset="70-78"
			type="HP" text="neoplasm" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="172-176"
			type="GENE" text="KRAS" ontology_id="3845"/>
		<entity id="s1.e3" charOffset="188-194"
			type="GENE" text="CDKN2A" ontology_id="1029"/>
		<entity id="s1.e4" charOffset="230-234"
			type="GENE" text="GNAS" ontology_id="2778"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="true"/>
	</sentence>
	<sentence id="s2" text="All intraductal tubulopapillary neoplasms revealed the characteristic histologic (cellular intraductal nodules of back-to-back tubular glands lined by predominantly cuboidal cells with atypical nuclei and no obvious intracellular mucin) and immunohistochemical (immunolabeled with MUC1 and MUC6 but were negative for MUC2 and MUC5AC) features.">
		<entity id="s2.e1" charOffset="32-40"
			type="HP" text="neoplasm" ontology_id="HP_0002664"/>
		<entity id="s2.e2" charOffset="290-294"
			type="GENE" text="MUC6" ontology_id="4588"/>
		<entity id="s2.e3" charOffset="317-321"
			type="GENE" text="MUC2" ontology_id="4583"/>
		<entity id="s2.e4" charOffset="326-332"
			type="GENE" text="MUC5AC" ontology_id="4586"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p3" e1="s2.e1"
		    e2="s2.e4" pgr="false"/>
	</sentence>
	<sentence id="s3" text="However, certain chromatin remodeling genes (MLL1, MLL2, MLL3, BAP1, PBRM1, EED, and ATRX) were found to be mutated in 7/22 (32%) of intraductal tubulopapillary neoplasms and 27% harbored phosphatidylinositol 3-kinase (PI3K) pathway (PIK3CA, PIK3CB, INPP4A, and PTEN) mutations.">
		<entity id="s3.e1" charOffset="63-67"
			type="GENE" text="BAP1" ontology_id="9223"/>
		<entity id="s3.e2" charOffset="69-74"
			type="GENE" text="PBRM1" ontology_id="55193"/>
		<entity id="s3.e3" charOffset="76-79"
			type="GENE" text="EED" ontology_id="8726"/>
		<entity id="s3.e4" charOffset="85-89"
			type="GENE" text="ATRX" ontology_id="546"/>
		<entity id="s3.e5" charOffset="161-169"
			type="HP" text="neoplasm" ontology_id="HP_0002664"/>
		<entity id="s3.e6" charOffset="242-248"
			type="GENE" text="PIK3CB" ontology_id="5291"/>
		<entity id="s3.e7" charOffset="250-256"
			type="GENE" text="INPP4A" ontology_id="3631"/>
		<entity id="s3.e8" charOffset="262-266"
			type="GENE" text="PTEN" ontology_id="5728"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p3" e1="s3.e3"
		    e2="s3.e5" pgr="false"/>
		<pair id="s3.p4" e1="s3.e4"
		    e2="s3.e5" pgr="true"/>
		<pair id="s3.p5" e1="s3.e5"
		    e2="s3.e6" pgr="false"/>
		<pair id="s3.p6" e1="s3.e5"
		    e2="s3.e7" pgr="false"/>
		<pair id="s3.p7" e1="s3.e5"
		    e2="s3.e8" pgr="true"/>
	</sentence>
	<sentence id="s4" text="In addition, 4/18 (18%) of intraductal tubulopapillary neoplasms had FGFR2 fusions (FGFR2-CEP55, FGFR2-SASS6, DISP1-FGFR2, FGFR2-TXLNA, and FGFR2-VCL) and 1/18 (5.5%) had STRN-ALK fusion.">
		<entity id="s4.e1" charOffset="55-63"
			type="HP" text="neoplasm" ontology_id="HP_0002664"/>
		<entity id="s4.e2" charOffset="69-74"
			type="GENE" text="FGFR2" ontology_id="2263"/>
		<entity id="s4.e3" charOffset="90-95"
			type="GENE" text="CEP55" ontology_id="55165"/>
		<entity id="s4.e4" charOffset="103-108"
			type="GENE" text="SASS6" ontology_id="163786"/>
		<entity id="s4.e5" charOffset="110-115"
			type="GENE" text="DISP1" ontology_id="84976"/>
		<entity id="s4.e6" charOffset="129-134"
			type="GENE" text="TXLNA" ontology_id="200081"/>
		<entity id="s4.e7" charOffset="171-175"
			type="GENE" text="STRN" ontology_id="6801"/>
		<entity id="s4.e8" charOffset="176-179"
			type="GENE" text="ALK" ontology_id="238"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="true"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p3" e1="s4.e1"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p4" e1="s4.e1"
		    e2="s4.e5" pgr="false"/>
		<pair id="s4.p5" e1="s4.e1"
		    e2="s4.e6" pgr="false"/>
		<pair id="s4.p6" e1="s4.e1"
		    e2="s4.e7" pgr="false"/>
		<pair id="s4.p7" e1="s4.e1"
		    e2="s4.e8" pgr="true"/>
	</sentence>
	<sentence id="s5" text="All intraductal tubulopapillary neoplasms revealed the characteristic histologic (cellular intraductal nodules of back-to-back tubular glands lined by predominantly cuboidal cells with atypical nuclei and no obvious intracellular mucin) and immunohistochemical (immunolabeled with MUC1 and MUC6 but were negative for MUC2 and MUC5AC) features.">
		<entity id="s5.e1" charOffset="32-40"
			type="HP" text="neoplasm" ontology_id="HP_0002664"/>
		<entity id="s5.e2" charOffset="281-285"
			type="GENE" text="MUC1" ontology_id="4582"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
</document>
